Gerassimos E. Voutsinas

Author

National Centre of Scientific Research "Demokritos"

Also Known As

G E Voutsinas, G Voutsinas, G. VOUTSINAS, G. Voutsinas, G.E. Voutsinas, Gerassimos E Voutsinas, Gerassimos E. Voutsinas, Gerassimos Voutsinas, Maria Miaouli, Voutsinas, G.E.

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

National Centre of Scientific Research "Demokritos"National and Kapodistrian University of Athens Institute of Biosciences & Applications Harvard University Dana-Farber Cancer Institute

About

Gerassimos E. Voutsinas is an author at National Centre of Scientific Research "Demokritos" specializing in medicine, cancer research, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	449
2	Biochemistry	4	4	97
3	Natural Sciences	2	2	32
4	Engineering	1	1	46
5	Public Health	1	1	34

Gerassimos E. Voutsinas

Publications

Citations

H-Index

Page 1

	Year	Citations
c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations Penelope Korkolopoulou, Athina Goudopoulou, Gerassimos E. Voutsinas, Urology Urological ResearchUrologyGenitourinary CancerC-flip ExpressionCell Death	2004	69
Epidermal Growth Factor Receptor as a Therapeutic Target in Human Thyroid Carcinoma: Mutational and Functional Analysis Constantine S. Mitsiades, Vassiliki Kotoula, Vassiliki Poulaki, The Journal of Clinical Endocrinology & Metabolism	2006	62
Allelic imbalance of expression and epigenetic regulation within the alpha-synuclein wild-type and p.Ala53Thr alleles in Parkinson disease Gerassimos E. Voutsinas, Eleana F. Stavrou, Gerassimos Karousos, Human Mutation	2010	61
Targeting <i>BRAF</i>V600E in thyroid carcinoma: therapeutic implications Constantine S. Mitsiades, Joseph Negri, Ciaran J. McMullan, Molecular Cancer Therapeutics Cancer BiologyTumor BiologyOncologyReceptor Tyrosine KinaseCancer Cell Biology	2007	57
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells Panagiotis K. Karkoulis, Dimitrios J. Stravopodis, Lukas H. Margaritis, BMC Cancer	2010	56
Fas Signaling in Thyroid Carcinomas Is Diverted from Apoptosis to Proliferation Constantine S. Mitsiades, Vassiliki Poulaki, Galinos Fanourakis, Clinical Cancer Research	2006	54
A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3 Tineke Timmer, P. Terpstra, Anke van den Berg, European Journal of Human Genetics Tumor HeterogeneityMedicineGeneticsExpression PatternsCancer Genomics	1999	53
Functional characterization of <i>CHEK2</i> variants in a <i>Saccharomyces cerevisiae</i> system Angeliki Delimitsou, Florentia Fostira, Despoina Kalfakakou, Human Mutation EngineeringFungal Cell BiologyGeneticsBreast Cancer FamiliesMolecular Biology	2019	46
3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants Eumorphia G. Konstantakou, Gerassimos E. Voutsinas, Athanassios D. Velentzas, Molecular Cancer	2015	44
Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas Vassiliki Kotoula, Helen Litsiou, Galinos Fanourakis, Endocrine Related Cancer	2009	43

Page 1